{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:24:59Z","timestamp":1777487099013,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["1711199341"],"award-info":[{"award-number":["1711199341"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS- 2023-00258840"],"award-info":[{"award-number":["RS- 2023-00258840"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR22C1363"],"award-info":[{"award-number":["HR22C1363"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbrc.2026.153620","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:54:46Z","timestamp":1773334486000},"page":"153620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of non-toxic AAV capsid variants with enhanced deep retinal transduction and extended distribution following subretinal delivery"],"prefix":"10.1016","volume":"812","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3830-1288","authenticated-orcid":false,"given":"Hoon","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-Eun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younkyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthukumar","family":"Elangovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-2562","authenticated-orcid":false,"given":"Na Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Jae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Wook","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153620_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preteyeres.2014.08.001","article-title":"Vector platforms for gene therapy of inherited retinopathies","volume":"43","author":"Trapani","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.bbrc.2026.153620_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molmed.2018.06.006","article-title":"Seeing the light after 25 years of retinal gene therapy","volume":"24","author":"Trapani","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153620_bib3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153620_bib4","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2026.153620_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnins.2017.00174","article-title":"Retinal gene therapy: surgical vector delivery in the translation to clinical trials","volume":"11","author":"Ochakovski","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153620_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2026.153620_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.153620_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/380364a0","article-title":"Organ targeting in vivo using phage display peptide libraries","volume":"380","author":"Pasqualini","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153620_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid modifications for targeting and improving the efficacy of AAV vectors","volume":"12","author":"B\u00fcning","year":"2019","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.bbrc.2026.153620_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.153620_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman Primates and piglets following high-dose intravenous administration of an Adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2026.153620_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Costa Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2026.153620_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrc.2026.153620_bib14","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.153620_bib15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1006\/mthe.2001.0345","article-title":"Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids","volume":"3","author":"Grifman","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2026.153620_bib16","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/JVI.00076-06","article-title":"Heparan sulfate proteoglycan binding properties of Adeno-associated virus retargeting mutants and consequences for their in vivo tropism","volume":"80","author":"Perabo","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2026.153620_bib17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/hum.2016.085","article-title":"Highly efficient delivery of Adeno-associated viral vectors to the primate retina","volume":"27","author":"Boye","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2026.153620_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.14.1.29","article-title":"Ocular safety and toxicology of subretinal gene therapy with rAAV.hPDE6A in nonhuman primates","volume":"14","author":"Seitz","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153620_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-2660(09)67002-4","article-title":"Adeno-associated viral vectors and their redirection to cell-type specific receptors","volume":"67","author":"Michelfelder","year":"2009","journal-title":"Adv. Genet."},{"key":"10.1016\/j.bbrc.2026.153620_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nm1445","article-title":"Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid","volume":"12","author":"Vandenberghe","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2026.153620_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017368","article-title":"Convergence of human genetics and animal studies: gene therapy for X-Linked retinoschisis","volume":"5","author":"Bush","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbrc.2026.153620_bib22","doi-asserted-by":"crossref","first-page":"32792","DOI":"10.1074\/jbc.M706321200","article-title":"Retinoschisin (RS1), the protein encoded by the X-linked retinoschisis gene, is anchored to the surface of retinal photoreceptor and bipolar cells through its interactions with a Na\/K ATPase-SARM1 complex","volume":"282","author":"Molday","year":"2007","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:33:18Z","timestamp":1777386798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26003840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":22,"alternative-id":["S0006291X26003840"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153620","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of non-toxic AAV capsid variants with enhanced deep retinal transduction and extended distribution following subretinal delivery","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153620"}}